Risk of the occurrence of gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in the postmolar follow-up - Revista Brasileira de Ginecologia e Obstetrícia
Matos MC, Braga Neto AR, Maestá I. Risk of the occurrence of gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in the postmolar follow-up. Rev Bras Ginecol Obstet 2014;36(11):529.
Electronic Document Format (ABNT)
Matos, Michelle Campos de; Braga Neto, Antonio Rodrigues; Maestá, Izildinha. Risk of the occurrence of gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in the postmolar follow-up. Rev Bras Ginecol Obstet, v. 36, n. 11, p. 529-529, Nov. 2014.
Electronic Document Format (APA)
Matos, M. C. , Braga Neto, A. R., & Maestá, I. (2014). Risk of the occurrence of gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in the postmolar follow-up. Rev Bras Ginecol Obstet, 36(11), 529-529.
Electronic Document Format (ISO)
Matos, Michelle Campos de and Braga Neto, Antonio Rodrigues and Maestá, Izildinha. Risk of the occurrence of gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in the postmolar follow-up. Rev Bras Ginecol Obstet [online]. 2014, vol. 36, n. 11, [cited 2024-06-28], pp.529-529. Available from: <https://journalrbgo.org/article/risk-of-the-occurrence-of-gestational-trophoblastic-neoplasia-after-human-chorionic-gonadotropin-normalization-in-the-postmolar-follow-up/>.
✕
Risk of the occurrence of gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in the postmolar follow-up |
Comments